Atıf İçin Kopyala
Sävendahl L., Battelino T., Brod M., Rasmussen M. H., Horikawa R., Juul R. V., ...Daha Fazla
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, cilt.105, sa.4, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
105
Sayı:
4
-
Basım Tarihi:
2020
-
Doi Numarası:
10.1210/clinem/dgz310
-
Dergi Adı:
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, Agricultural & Environmental Science Database, BIOSIS, CAB Abstracts, Chemical Abstracts Core, CINAHL, EMBASE, Food Science & Technology Abstracts, Gender Studies Database, MEDLINE, Veterinary Science Database
-
Anahtar Kelimeler:
growth hormone, growth hormone deficiency, growth hormone replacement therapy, long-acting growth hormone, somapacitan, treatment burden, GROWTH-HORMONE, REFERENCE INTERVALS, IGF-I, INSULIN, MULTICENTER, POSSESSES, SAFETY, ANALOG
-
Marmara Üniversitesi Adresli:
Evet
Özet
Context: Daily growth hormone (GH) injections can be burdensome for patients and carers. Somapacitan is a long-acting, reversible albumin-binding GH derivative in development for once-weekly administration in patients with growth hormone deficiency (GHD).